Nothing Special   »   [go: up one dir, main page]

FR2758331B1 - NEW MEANS FOR DIAGNOSIS, PREVENTION AND TREATMENT FOR CONTAMINATION OR INFECTIONS WITH MUCOUS TROPISM VIRUSES - Google Patents

NEW MEANS FOR DIAGNOSIS, PREVENTION AND TREATMENT FOR CONTAMINATION OR INFECTIONS WITH MUCOUS TROPISM VIRUSES

Info

Publication number
FR2758331B1
FR2758331B1 FR9700300A FR9700300A FR2758331B1 FR 2758331 B1 FR2758331 B1 FR 2758331B1 FR 9700300 A FR9700300 A FR 9700300A FR 9700300 A FR9700300 A FR 9700300A FR 2758331 B1 FR2758331 B1 FR 2758331B1
Authority
FR
France
Prior art keywords
tropism
mucous
infections
viruses
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9700300A
Other languages
French (fr)
Other versions
FR2758331A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Bourgogne
Original Assignee
Universite de Bourgogne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Bourgogne filed Critical Universite de Bourgogne
Priority to FR9700300A priority Critical patent/FR2758331B1/en
Priority to EP97953956A priority patent/EP0953050A1/en
Priority to PCT/FR1997/002433 priority patent/WO1998031807A1/en
Publication of FR2758331A1 publication Critical patent/FR2758331A1/en
Application granted granted Critical
Publication of FR2758331B1 publication Critical patent/FR2758331B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR9700300A 1997-01-14 1997-01-14 NEW MEANS FOR DIAGNOSIS, PREVENTION AND TREATMENT FOR CONTAMINATION OR INFECTIONS WITH MUCOUS TROPISM VIRUSES Expired - Fee Related FR2758331B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9700300A FR2758331B1 (en) 1997-01-14 1997-01-14 NEW MEANS FOR DIAGNOSIS, PREVENTION AND TREATMENT FOR CONTAMINATION OR INFECTIONS WITH MUCOUS TROPISM VIRUSES
EP97953956A EP0953050A1 (en) 1997-01-14 1997-12-26 Novel means for the diagnosis, prevention and treatment of contamination or infections by viruses with mucous tropism
PCT/FR1997/002433 WO1998031807A1 (en) 1997-01-14 1997-12-26 Novel means for the diagnosis, prevention and treatment of contamination or infections by viruses with mucous tropism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9700300A FR2758331B1 (en) 1997-01-14 1997-01-14 NEW MEANS FOR DIAGNOSIS, PREVENTION AND TREATMENT FOR CONTAMINATION OR INFECTIONS WITH MUCOUS TROPISM VIRUSES

Publications (2)

Publication Number Publication Date
FR2758331A1 FR2758331A1 (en) 1998-07-17
FR2758331B1 true FR2758331B1 (en) 1999-03-05

Family

ID=9502577

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9700300A Expired - Fee Related FR2758331B1 (en) 1997-01-14 1997-01-14 NEW MEANS FOR DIAGNOSIS, PREVENTION AND TREATMENT FOR CONTAMINATION OR INFECTIONS WITH MUCOUS TROPISM VIRUSES

Country Status (3)

Country Link
EP (1) EP0953050A1 (en)
FR (1) FR2758331B1 (en)
WO (1) WO1998031807A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7700735B2 (en) 2000-03-01 2010-04-20 Medimmune, Llc High potency recombinant antibodies and method for producing them
US7740851B2 (en) 2000-01-27 2010-06-22 Medimmune, Llc Ultra high affinity neutralizing antibodies
US7785592B2 (en) 2002-06-14 2010-08-31 Medimmune, Llc Stabilized liquid anti-RSV antibody formulations
US7847082B2 (en) 2000-11-28 2010-12-07 Medimmune, Llc Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US8562996B2 (en) 2007-06-01 2013-10-22 Medimmune Limited RSV-specific binding molecules and means for producing them
US9283274B2 (en) 2009-10-06 2016-03-15 Medimmune Limited RSV specific binding molecule

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7425618B2 (en) 2002-06-14 2008-09-16 Medimmune, Inc. Stabilized anti-respiratory syncytial virus (RSV) antibody formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9207479D0 (en) * 1992-04-06 1992-05-20 Scotgen Ltd Novel antibodies for treatment and prevention of respiratory syncytial virus infection in animals and man
US5762905A (en) * 1992-09-16 1998-06-09 The Scripps Research Institute Human neutralizing monoclonal antibodies to respiratory syncytial virus
CA2167835A1 (en) * 1993-07-30 1995-02-09 Richard A. Weltzin Monoclonal iga antibody against respiratory syncytial virus
US5811524A (en) * 1995-06-07 1998-09-22 Idec Pharmaceuticals Corporation Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7740851B2 (en) 2000-01-27 2010-06-22 Medimmune, Llc Ultra high affinity neutralizing antibodies
US7700735B2 (en) 2000-03-01 2010-04-20 Medimmune, Llc High potency recombinant antibodies and method for producing them
US8153133B2 (en) 2000-03-01 2012-04-10 Medimmune, Llc High potency recombinant antibodies and method for producing them
US7847082B2 (en) 2000-11-28 2010-12-07 Medimmune, Llc Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US7785592B2 (en) 2002-06-14 2010-08-31 Medimmune, Llc Stabilized liquid anti-RSV antibody formulations
US8007793B2 (en) 2002-06-14 2011-08-30 Medimmune, Llc Stabilized liquid anti-RSV antibody formulations
US8206951B2 (en) 2002-06-14 2012-06-26 Medimmune, Llc Stabilized liquid anti-RSV antibody formulations
US8460663B2 (en) 2002-06-14 2013-06-11 Medimmune, Llc Stabilized liquid anti-RSV antibody formulations
US8986686B2 (en) 2002-06-14 2015-03-24 Medimmune, Llc Stabilized liquid anti-RSV antibody formulations
US9272032B2 (en) 2002-06-14 2016-03-01 Medimmune, Llc Stabilized liquid anti-RSV antibody formulations
US8562996B2 (en) 2007-06-01 2013-10-22 Medimmune Limited RSV-specific binding molecules and means for producing them
US9283274B2 (en) 2009-10-06 2016-03-15 Medimmune Limited RSV specific binding molecule

Also Published As

Publication number Publication date
WO1998031807A1 (en) 1998-07-23
FR2758331A1 (en) 1998-07-17
EP0953050A1 (en) 1999-11-03

Similar Documents

Publication Publication Date Title
IT1306566B1 (en) ADJUSTABLE SYSTEM FOR INSERTING AND REMOVING THE ROTORIC PACK OF ROTARY COMPRESSORS.
ID27457A (en) COMPOSITION FOR HIV TREATMENT AND OTHER VIRUS INFECTIONS
ZA964694B (en) Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection.
TNSN95046A1 (en) DOSAGE FORMS OF AZITHROMYCIN FOR THE TREATMENT OF MICROBIAL INFECTIONS
HK1043625A1 (en) Kidney disease detection and treatment
DZ2028A1 (en) Medicines used to treat bacterial infections in pediatrics.
FR2758331B1 (en) NEW MEANS FOR DIAGNOSIS, PREVENTION AND TREATMENT FOR CONTAMINATION OR INFECTIONS WITH MUCOUS TROPISM VIRUSES
MA26896A1 (en) USE OF AZALIDE ANTIBIOTIC COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF BACTERIA OR PROTOZOA INFECTION IN MAMMALS
FR2716881B1 (en) Process for the preparation and purification of Iopamidol.
FR2716633B1 (en) Stirrer and suction tube device.
ITVR940096A0 (en) PROCEDURE AND EQUIPMENT FOR THE SPECIFIC IMMUNADORPTION OF HIV VIRUS, GP120 ANTIGEN AND CD4-GP120 COMPLEX.
EE03514B1 (en) A combination of compounds for the treatment of HIV infection or AIDS, its use and a pharmaceutical composition
MA26650A1 (en) OXO-THIA -AZABICYCLOOCTENES, PHARMACEUTICAL PREPARATIONS CONTAINING THEM, AND THEIR USE FOR THE TREATMENT AND PROPHYLAXIS OF INFECTIOUS DISEASES.
EE9600190A (en) A pharmaceutical composition for the prevention and / or treatment of viral infections and possible concomitant inflammations and a method of treating said diseases
HU9502128D0 (en) Marek's disease virus vaccine
ATE240123T1 (en) RADIOPHARMACEUTICAL AGENTS FOR IMAGING INFECTIONS AND INFLAMMATIONS
MA24586A1 (en) DOSAGE FORMS OF SERTRALINE AND PROCESS FOR THEIR PREPARATION.
IT1289238B1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS INCLUDING A 4 ARILCUMARIN
FR2713517B1 (en) Cyclonic exchanger for air purification and depollution.
FR2715850B1 (en) Hospital waste treatment system.
LU90068B1 (en) Condensation evacuator for air or gas treatment installations in general
FI963753A (en) New drug for treating viral disease in respiratory tract
AU3651595A (en) Drug for the prevention and treatment of auto-immune and viral diseases, and diagnostic agents for detecting said diseases
FR2717172B1 (en) Porous body comprising aluminum nitride particles, their preparation process and their applications.
FR2715067B1 (en) New dosage form of 5-nitro-imidazole derivatives effective for the treatment of parasitic infections and infections of the entire gastrointestinal tract.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20091030